ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine
(group practice)

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,731Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 26

$1.04M Total Retail Price of All Prescriptions

Rank: 1 out of 26

405 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 405 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

4% of this provider’s 405 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 13,240 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 33%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 839 756 1 1
DONEPEZIL HCL 501 475 2 18
METOPROLOL TARTRATE 470 389 3 8
SIMVASTATIN 426 341 4 2
ATORVASTATIN CALCIUM 419 351 5 5
FUROSEMIDE 389 330 6 7
CLOPIDOGREL 349 264 7 21
METFORMIN HCL 327 272 8 4
OMEPRAZOLE 304 214 9 6
FAMOTIDINE 265 218 10 29
HUMALOG 243 151 11 39
IPRATROPIUM-ALBUTEROL 240 192 12 40
CARVEDILOL 239 153 13 13
WARFARIN SODIUM 239 177 13 14
LISINOPRIL 231 195 15 10
LEVOTHYROXINE SODIUM 230 192 16 3
RISPERIDONE 226 149 17 44
PLAVIX 220 178 18 24
ENALAPRIL MALEATE 211 180 19 17
ESCITALOPRAM OXALATE 204 161 20 30
PRANDIN 200 186 21 50
FENTANYL 180 118 S2 22 55
NAMENDA 179 178 23 37
TRAMADOL HCL 174 139 24 28
DIOVAN 173 143 25 12
CLONIDINE HCL 169 154 26 42
METOPROLOL SUCCINATE 163 119 27 9
ALENDRONATE SODIUM 154 129 28 22
GABAPENTIN 146 97 29 34
NITROGLYCERIN PATCH 143 125 30 61
OXYCODONE-ACETAMINOPHEN 141 62 S2 31 38
HYDRALAZINE HCL 139 126 32 62
ALBUTEROL SULFATE 132 128 33 48
POTASSIUM CHLORIDE 125 98 34 26
SERTRALINE HCL 123 83 35 54
HYDROCHLOROTHIAZIDE 123 89 35 11
SANTYL 120 85 37 68
ADVAIR DISKUS 117 87 38 41
NOVOLOG 116 94 39 71
LEVEMIR 116 92 39 71
LANTUS 115 74 41 73
ENOXAPARIN SODIUM 114 98 42 74
TRAVATAN Z 108 103 43 75
LOSARTAN POTASSIUM 105 68 44 16
MUPIROCIN 104 85 45 47
DIOVAN HCT 104 85 45 23
LEVOFLOXACIN 97 70 47 58
CRESTOR 96 89 48 19
PHENYTOIN SODIUM EXTENDED 96 63 48 77
JANUVIA 94 55 50 51
ACETAMINOPHEN-CODEINE 93 59 S3 51 79
PREDNISONE 91 74 52 46
PANTOPRAZOLE SODIUM 90 82 53 81
LATANOPROST 85 65 54 85
LIDODERM 84 71 55 57
ZOLPIDEM TARTRATE 84 67 55 27
TAMSULOSIN HCL 80 77 57 64
LACTULOSE 79 55 58 87
TRIAMTERENE-HCTZ 79 52 58 87
GLYBURIDE-METFORMIN HCL 78 63 R 60 56
CLOTRIMAZOLE-BETAMETHASONE 68 54 61 96
SPIRONOLACTONE 67 46 62 63
AZITHROMYCIN 66 49 63 33
CAPTOPRIL 65 59 64 99
PRAVASTATIN SODIUM 63 55 65 15
CARBIDOPA-LEVODOPA 62 49 66 65
PROAIR HFA 61 48 67 102
LIPITOR 61 53 67 43
ALLOPURINOL 60 42 69 31
OXYBUTYNIN CHLORIDE 58 39 70 109
RAMIPRIL 56 51 71 49
METOCLOPRAMIDE HCL 55 19 72 111
OXYBUTYNIN CHLORIDE ER 54 54 73 113
AMLODIPINE BESYLATE-BENAZEPRIL 53 48 74 75
LEVETIRACETAM 53 28 74 116
MIRTAZAPINE 51 37 76 120
PROMETHAZINE HCL 50 34 R 77 122
NIFEDIPINE ER 50 35 77 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.